Cannabist Co. Holdings Aktie Logo
CA13765Y1034
A3EV8J
CBST.NE

Cannabist Co. Holdings Aktie

Caricamento quotazioni...

Previsioni

Acquista
  1
Mantieni
  0
Vendi
  0

  • The Cannabist Company sells Virginia business to Curaleaf for $110 million

    The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Altro su de.investing.com


  • Cannabist Company reports revenue decline and falling EBITDA in Q3 2025

    Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Altro su de.investing.com


  • Cannabist Company reports revenue decline and share price loss due to restructuring

    Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, Cannabist Co. Holdings Aktie ha registrato ricavi pari a 68,1 Mln € e un utile netto di -12,15 Mln €
(EUR) settembre 2025
YoY
Ricavi 68,1 Mln -
Utile lordo 19,52 Mln -
Utile netto -12,15 Mln -
EBITDA 6,65 Mln -

Dati fondamentali

Metrica Valore
Capitalizzazione di mercato
12,92 Mln €
Numero di azioni
497,46 Mln
Massimo/minimo a 52 settimane
0,14 € - 0,0178 €
Dividendi No
Beta
1,05
Rapporto P/E
-0,15
Rapporto PEG
0,00
Rapporto P/B
-0,10
Rapporto P/S
0,09

Profilo aziendale

The Cannabist Company Holdings Inc. si occupa della coltivazione, produzione e fornitura di prodotti a base di cannabis e di servizi correlati negli Stati Uniti e a livello internazionale. La società offre prodotti che spaziano da fiori, edibles, oli e compresse, commercializzati con i marchi Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press e Amber. Detiene licenze in 17 giurisdizioni negli Stati Uniti. In precedenza la società era nota come Columbia Care Inc. e ha cambiato il proprio nome in The Cannabist Company Holdings Inc. nel settembre 2023. La società è stata fondata nel 2012 ed ha sede a New York, New York.

Nome
Cannabist Co. Holdings Aktie
CEO
Christopher Marr
Sede centrale Malvern, pa
Stati Uniti
Sito web
Quotazione in borsa
29/04/2019
Dipendenti 2829

Simboli di borsa

Borsa Simbolo
Neo
CBST.NE
Pnk
CBSTF
Frankfurt
VW5.F
Düsseldorf
VW5.DU
München
VW5.MU
🍪

Parqet  usa i cookie. Scopri di più